Affinivax is a clinical-stage biopharma company that develops and commercializes novel MAPS vaccines for the treatment of infectious diseases. Affinivax was founded in 2014. Affinivax's headquarters is located in Cambridge, Massachusetts, USA 02142. I... Affinivax's President & CEO, Steven Brugger, currently has an approval
rating of 86%. Affinivax's primary competitors are Oragenics, Paratek & Melinta.
There have been no acquisitions found related to Affinivax
Recent investment data cannot be found related to Affinivax